A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

Conditions:   Covid19;   SARS (Severe Acute Respiratory Syndrome);   SARS-CoV Infection;   SARS-CoV-2 Interventions:   Biological: Biological: oral polio vaccine;   Biological: Comparable Placebo;   Drug: NA-831;   Drug: Comparable Placebo of drug;   Combination Product: Combination of oral polio vaccine and NA-831;   Combination Product: Comparable Placebo of Oral Polio Vaccine and Placebo of dr ug Sponsors:   NeuroActiva, Inc.;   Biomed Industries, Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials